# Oral Prednisolone in Severe Acute Exacerbation of Chronic Obstructive Pulmonary Disease (COPD)

> **NCT01353235** · PHASE3 · COMPLETED · sponsor: **Fekri Abroug** · enrollment: 317 (actual)

## Conditions studied

- COPD Exacerbation

## Interventions

- **DRUG:** Prednisolone
- **DRUG:** usual care

## Key facts

- **NCT ID:** NCT01353235
- **Lead sponsor:** Fekri Abroug
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-04
- **Primary completion:** 2013-06
- **Final completion:** 2013-06
- **Target enrollment:** 317 (ACTUAL)
- **Last updated:** 2017-08-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01353235

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01353235, "Oral Prednisolone in Severe Acute Exacerbation of Chronic Obstructive Pulmonary Disease (COPD)". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT01353235. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*